Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 7, 2018

View Archived Issues

Study gives clues to mitigating pneumonia risk after flu

Structural tuning yields tuberculosis fighter

CRISPR bad news, but with a fix

Crunching the data on CRP

Silencing SOD1 with miRNA for SOD1-linked ALS

New insights into microexon regulation

Fat and fibroblasts

GlycoMimetics initiates phase III trial of uproleselan in relapsed/refractory AML

YC-6 exhibits safety and tolerability in first-in-human study

Deubiquitinase Usp12 is neuroprotective in Huntington's disease neurons

Discovery of new envelope-based antigen that triggers potent humoral responses against HIV-1

INS-3001 demonstrates efficacy in rat model of vascular calcifications

Enesi and Sementis collaborate on solid dose vaccine development

Corcept Therapeutics enrolling participants in phase III study of relacorilant

CF-MEV-132 reduces lung damage in rat model of hyperoxia-induced bronchopulmonary dysplasia

Platelet-targeting vaccine may reduce post-stroke blood clot risk

MC-RG19, a novel 5-HT7 receptor antagonist, reduces hypothermia in rats

Upadacitinib demonstrates efficacy in treating ulcerative colitis

Universita di Pisa patents AMPK subunit alpha-2 activators

Novintum Biotechnology presents new doxycycline derivatives for cancer

FDA clears IND for herpes zoster vaccine candidate CRV-101

FDA approves Empliciti plus pomalidomide and dexamethasone for relapsed/refractory multiple myeloma

DSMB recommends discontinuation of phase III study of PREOB for osteonecrosis

Secarna and MetP to codevelop transnasal antisense oligonucleotide-based CNS therapeutics

Sosei collaborates with DyNAbind to accelerate GPCR drug discovery

Tonix presents retrospective analyses from phase III HONOR study of Tonmya in PTSD

BioNTech and University of Pennsylvania collaborate on mRNA-based vaccines for infectious disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...